Nobelpharma Chooses Maryland For First Overseas Subsidiary

URLhttps://businessfacilities.com/2020/09/nobelpharma
SourceBusiness Facilities
Date Published09/01/2020
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Nobelpharma America, LLC
Parent companyNobelpharma Co., Ltd.
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):20
Year reshoring announced:2020
Year reshoring implemented or to be implemented:2020
Domestically, the work will be done:In-house
Country(ies) from which reshored:Japan
City reshored to:Bethesda
State(s) reshored to:MD
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredpharmaceuticals
What non-domestic negative factors made offshoring less attractive?Regulatory compliance
What domestic positive factors made reshoring more attractive?Eco-system synergies, Government Incentives, Proximity to customers/market, proximity to NIH and regulators
Find Reshoring Articles